-
2
-
-
3843085422
-
Indian Medical Association wants off-label prescribing
-
NO AUTHORS LISTED: Indian Medical Association wants off-label prescribing. BMJ (2004) 328:974.
-
(2004)
BMJ
, vol.328
, pp. 974
-
-
AUTHORS LISTED, N.1
-
3
-
-
38649095345
-
Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice
-
ROYAL COLLEGE OF PSYCHIATRISTS:, CR142. Royal College of Psychiatrists London, UK
-
ROYAL COLLEGE OF PSYCHIATRISTS: Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice. College Report CR142. Royal College of Psychiatrists London, UK (2007).
-
(2007)
College Report
-
-
-
4
-
-
0032853345
-
Off-label prescribing: Legal implications
-
HENRY V: Off-label prescribing: legal implications. J. Legal Med. (1999) 20:365-383.
-
(1999)
J. Legal Med
, vol.20
, pp. 365-383
-
-
HENRY, V.1
-
5
-
-
0029039326
-
Risk: Benefit analysis of drugs in practice
-
NO AUTHORS LISTED: Risk: benefit analysis of drugs in practice. Drug Ther. Bull. (1995) 5:33-35.
-
(1995)
Drug Ther. Bull
, vol.5
, pp. 33-35
-
-
AUTHORS LISTED, N.1
-
6
-
-
0031763286
-
Prescriptions, licences and evidence
-
HEALY D, NUTT D: Prescriptions, licences and evidence. Psychiatr. Bull. (1998) 22:680-684.
-
(1998)
Psychiatr. Bull
, vol.22
, pp. 680-684
-
-
HEALY, D.1
NUTT, D.2
-
8
-
-
31744433268
-
Off-label prescribing by psychiatrists
-
HODGSON R, BELGAMWAR R: Off-label prescribing by psychiatrists. Psychiatr. Bull. (2006) 30:55-57.
-
(2006)
Psychiatr. Bull
, vol.30
, pp. 55-57
-
-
HODGSON, R.1
BELGAMWAR, R.2
-
9
-
-
0037160179
-
An analysis of off-licence prescribing in psychiatric medicine
-
DOUGLAS-HALL P, FULLER A, GILL-BANHAM S: An analysis of off-licence prescribing in psychiatric medicine. Pharm. J. (2001) 267:890-891.
-
(2001)
Pharm. J
, vol.267
, pp. 890-891
-
-
DOUGLAS-HALL, P.1
FULLER, A.2
GILL-BANHAM, S.3
-
10
-
-
0035286571
-
From clinical trials to real-world practice: Use of atypical antipsychotic medication nationally in the Department of Veterans Affairs
-
ROSENHECK R, LESLIE D, SERNYAK M: From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs. Med. Care (2001) 39:302-308.
-
(2001)
Med. Care
, vol.39
, pp. 302-308
-
-
ROSENHECK, R.1
LESLIE, D.2
SERNYAK, M.3
-
11
-
-
17644392108
-
Antipsychotic prescribing pattern among Italian general practitioners: A population-based study during the years 1999-2002
-
TRIFIRÒ G, SPINA E, BRIGNOLI O et al.: Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. Eur. J. Clin. Pharmacol. (2005) 61:47-53.
-
(2005)
Eur. J. Clin. Pharmacol
, vol.61
, pp. 47-53
-
-
TRIFIRÒ, G.1
SPINA, E.2
BRIGNOLI, O.3
-
12
-
-
1642564419
-
Off-label and non-classical prescriptions of antipsychotic agents in ordinary in-patient practice
-
BARBUI C, CIUNA A, NOSÉ M et al.: Off-label and non-classical prescriptions of antipsychotic agents in ordinary in-patient practice. Acta Psych. Scand. (2004) 109:275-278.
-
(2004)
Acta Psych. Scand
, vol.109
, pp. 275-278
-
-
BARBUI, C.1
CIUNA, A.2
NOSÉ, M.3
-
13
-
-
0033711757
-
Off-label use of antipsychotic drugs
-
WEISS E, HUMMER M, KOLLER D, ULMER H, FLEISCHHACKER WW: Off-label use of antipsychotic drugs. J. Clin. Psychopharmacol. (2000) 20:695-698.
-
(2000)
J. Clin. Psychopharmacol
, vol.20
, pp. 695-698
-
-
WEISS, E.1
HUMMER, M.2
KOLLER, D.3
ULMER, H.4
FLEISCHHACKER, W.W.5
-
14
-
-
0038169046
-
Factors associated with antipsychotic drug use in residential care: Changes between 1990 and 1997
-
LINDESAY J, MATTHEWS R, JAGGER C: Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997. Int. J. Geriatr. Psychiatry (2003) 18:511-519.
-
(2003)
Int. J. Geriatr. Psychiatry
, vol.18
, pp. 511-519
-
-
LINDESAY, J.1
MATTHEWS, R.2
JAGGER, C.3
-
15
-
-
23844525149
-
Antipsychotic use in the elderly: Shifting trends and increasing costs
-
RAPOPORT M, MAMDANI M, SHULMAN KI, HERRMAN N, ROCHON PA: Antipsychotic use in the elderly: shifting trends and increasing costs. Int. J. Geriatr. Psychiatry (2005) 20:749-753.
-
(2005)
Int. J. Geriatr. Psychiatry
, vol.20
, pp. 749-753
-
-
RAPOPORT, M.1
MAMDANI, M.2
SHULMAN, K.I.3
HERRMAN, N.4
ROCHON, P.A.5
-
16
-
-
29944447802
-
Why and how antipsychotic drugs are used in 40 Sydney nursing homes
-
SNOWDON J, DAY S, BAKER W: Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int. J. Geriatr. Psychiatry (2005) 20:1146-1152.
-
(2005)
Int. J. Geriatr. Psychiatry
, vol.20
, pp. 1146-1152
-
-
SNOWDON, J.1
DAY, S.2
BAKER, W.3
-
18
-
-
0242468514
-
Prescribing practices of community child and adolescent psychiatrists
-
DOERRY U, KENT L: Prescribing practices of community child and adolescent psychiatrists. Psychiatr. Bull. (2003) 27:407-410.
-
(2003)
Psychiatr. Bull
, vol.27
, pp. 407-410
-
-
DOERRY, U.1
KENT, L.2
-
19
-
-
19344378756
-
Trends in the use of typical and atypical antipsychotics in children and adolescents
-
PATEL NC, CRISMON ML, HOAGWOOD K et al.: Trends in the use of typical and atypical antipsychotics in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44:548-556.
-
(2005)
J. Am. Acad. Child Adolesc. Psychiatry
, vol.44
, pp. 548-556
-
-
PATEL, N.C.1
CRISMON, M.L.2
HOAGWOOD, K.3
-
20
-
-
33645737575
-
Trends in prescribing of antipsychotic medications for US children
-
COOPER WO, ARBOGAST PG, DING H et al.: Trends in prescribing of antipsychotic medications for US children. Ambul. Pediatr. (2006) 6:79-83.
-
(2006)
Ambul. Pediatr
, vol.6
, pp. 79-83
-
-
COOPER, W.O.1
ARBOGAST, P.G.2
DING, H.3
-
21
-
-
0031812858
-
Prevalence and patterns of psychotropic and anticonvulsant medication in use in children and adolescents referred to residential treatment
-
CONNOR DF, OZBAYRAK KR, HARRISON RJ et al.: Prevalence and patterns of psychotropic and anticonvulsant medication in use in children and adolescents referred to residential treatment. J. Am. Acad. Child Adolesc. Psychopharm. (1998) 8:27-38.
-
(1998)
J. Am. Acad. Child Adolesc. Psychopharm
, vol.8
, pp. 27-38
-
-
CONNOR, D.F.1
OZBAYRAK, K.R.2
HARRISON, R.J.3
-
23
-
-
1942469582
-
Regional variation and clinical indicators of antipsychotic use in residential treatment: A four-state comparison
-
RAWAL PH, LYONS JS, MACINTYRE JC, HUNTER JC: Regional variation and clinical indicators of antipsychotic use in residential treatment: a four-state comparison. J. Behav. Health Serv. Res. (2004) 31:178-188.
-
(2004)
J. Behav. Health Serv. Res
, vol.31
, pp. 178-188
-
-
RAWAL, P.H.1
LYONS, J.S.2
MACINTYRE, J.C.3
HUNTER, J.C.4
-
24
-
-
0035432299
-
Psychotropic medication in children: A study from the Netherlands
-
SCHIRM E, TOBI H, ZITO JM, DE JONG-VAN DEN BERG LT: Psychotropic medication in children: a study from the Netherlands. Pediatrics (2001) 108:E25.
-
(2001)
Pediatrics
, vol.108
-
-
SCHIRM, E.1
TOBI, H.2
ZITO, J.M.3
DE JONG-VAN, D.B.L.4
-
25
-
-
0031772964
-
Antipsychotic drugs for non-psychotic patients: Assessment of the benefit/risk ratio in generalised anxiety disorder
-
EL-KHAYAT R, BALDWIN DS: Antipsychotic drugs for non-psychotic patients: assessment of the benefit/risk ratio in generalised anxiety disorder. J. Psychopharmacol. (1998) 12(4):323-329.
-
(1998)
J. Psychopharmacol
, vol.12
, Issue.4
, pp. 323-329
-
-
EL-KHAYAT, R.1
BALDWIN, D.S.2
-
26
-
-
27644534854
-
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology
-
BALDWIN DS, ANDERSON IM, NUTT DJ et al.: Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. (2005) 19:567-596.
-
(2005)
J. Psychopharmacol
, vol.19
, pp. 567-596
-
-
BALDWIN, D.S.1
ANDERSON, I.M.2
NUTT, D.J.3
-
27
-
-
0022610150
-
Effective short-term treatment of anxiety: A double-blind trial
-
MENDELS J, KRAJEWSKI TF, HUFFER V: Effective short-term treatment of anxiety: a double-blind trial. J. Clin. Psychiatry (1986) 47:170-174.
-
(1986)
J. Clin. Psychiatry
, vol.47
, pp. 170-174
-
-
MENDELS, J.1
KRAJEWSKI, T.F.2
HUFFER, V.3
-
28
-
-
33750063164
-
Efficacy of typical and a typical antipsychotics for primary and comorbid anxiety symptoms or disorders: A review
-
GAO K, MUZINA D, GAJWANI P, CALABRESE JR: Efficacy of typical and a typical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J. Clin. Psychiatry (2006) 67:1327-1340.
-
(2006)
J. Clin. Psychiatry
, vol.67
, pp. 1327-1340
-
-
GAO, K.1
MUZINA, D.2
GAJWANI, P.3
CALABRESE, J.R.4
-
29
-
-
32144450616
-
Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: A placebo controlled study
-
POLLACK MH, SIMON NM, ZALTA AK: Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol. Psychiatry (2006) 59:211-215.
-
(2006)
Biol. Psychiatry
, vol.59
, pp. 211-215
-
-
POLLACK, M.H.1
SIMON, N.M.2
ZALTA, A.K.3
-
30
-
-
39749176354
-
Adjunctive risperidone in generalized anxiety disorder: A double-blind placebo-controlled study
-
BRAWMAN-MINTZER O, KNAPP RG, NIETERT PJ: Adjunctive risperidone in generalized anxiety disorder: a double-blind placebo-controlled study. J. Clin. Psychiatry (2006) 67:1307-1308.
-
(2006)
J. Clin. Psychiatry
, vol.67
, pp. 1307-1308
-
-
BRAWMAN-MINTZER, O.1
KNAPP, R.G.2
NIETERT, P.J.3
-
32
-
-
33645233540
-
A review of antipsychotics in the treatment of obsessive compulsive disorder
-
FINEBERG NA, GALE TM, SIVAKUMARAN T: A review of antipsychotics in the treatment of obsessive compulsive disorder. J. Psychopharmacol. (2006) 20(1):97-103.
-
(2006)
J. Psychopharmacol
, vol.20
, Issue.1
, pp. 97-103
-
-
FINEBERG, N.A.1
GALE, T.M.2
SIVAKUMARAN, T.3
-
33
-
-
33751172334
-
Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: A meta-analysis of the randomized controlled trials
-
SKAPINAKIS P, PAPATHEODOROU T, MAVREAS V: Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Eur. Neuropsychopharmacol. (2006) 17:79-93.
-
(2006)
Eur. Neuropsychopharmacol
, vol.17
, pp. 79-93
-
-
SKAPINAKIS, P.1
PAPATHEODOROU, T.2
MAVREAS, V.3
-
34
-
-
39749097949
-
Antipsychotics in obsessive-compulsive disorder
-
MAINA G, UMBERTO A, PESSINA E, VIRGINIO S, BOGETTO F: Antipsychotics in obsessive-compulsive disorder. Curr. Psych. Rev. (2005) 1:293-301.
-
(2005)
Curr. Psych. Rev
, vol.1
, pp. 293-301
-
-
MAINA, G.1
UMBERTO, A.2
PESSINA, E.3
VIRGINIO, S.4
BOGETTO, F.5
-
35
-
-
0037239597
-
Antipsychotic augmentation for treatment-resistant obsessive compulsive disorder
-
MAINA G, ALBERT U, ZIERO S. BOGETTO F: Antipsychotic augmentation for treatment-resistant obsessive compulsive disorder. Int. Clin. Psychopharmacol. (2003) 18:23-28.
-
(2003)
Int. Clin. Psychopharmacol
, vol.18
, pp. 23-28
-
-
MAINA, G.1
ALBERT, U.2
ZIERO, S.3
BOGETTO, F.4
-
36
-
-
42749098607
-
Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders
-
CD005473
-
IPSER JC, CAREY P, DHANSAY Y et al.: Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst. Rev. (2006) 4:CD005473.
-
(2006)
Cochrane Database Syst. Rev
, vol.4
-
-
IPSER, J.C.1
CAREY, P.2
DHANSAY, Y.3
-
37
-
-
84904507502
-
Posttraumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care
-
NATIONAL COLLABORATING CENTRE FOR MENTAL HEALTH:, Gaskell and British Psychological Society
-
NATIONAL COLLABORATING CENTRE FOR MENTAL HEALTH: Posttraumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care. National Clinical Practice Guideline Number 26. Gaskell and British Psychological Society (2005).
-
(2005)
National Clinical Practice Guideline
, Issue.26
-
-
-
38
-
-
39749194051
-
Review: Antidepressant plus antipsychotic increases clinical response rates in psychotic depression
-
CIPRIANI A, BARBUI C: Review: antidepressant plus antipsychotic increases clinical response rates in psychotic depression. Evid. Based Ment. Health (2007) 10:10.
-
(2007)
Evid. Based Ment. Health
, vol.10
, pp. 10
-
-
CIPRIANI, A.1
BARBUI, C.2
-
39
-
-
33644875474
-
Pharmacological treatment for psychotic depression
-
CD004044
-
WIJKSTRA J, LIJMER J, BALK F, GEDDES J, NOLEN WA: Pharmacological treatment for psychotic depression. Cochrane Database Syst. Rev. (2005) 4:CD004044.
-
(2005)
Cochrane Database Syst. Rev
, vol.4
-
-
WIJKSTRA, J.1
LIJMER, J.2
BALK, F.3
GEDDES, J.4
NOLEN, W.A.5
-
40
-
-
33744955788
-
Psychotic major depression a benefit: Risk assessment of treatment options
-
TYRKA AR, PRICE LH, MELLO MF, CARPENTER LL: Psychotic major depression a benefit: risk assessment of treatment options. Drug Saf. (2006) 29:491-508.
-
(2006)
Drug Saf
, vol.29
, pp. 491-508
-
-
TYRKA, A.R.1
PRICE, L.H.2
MELLO, M.F.3
CARPENTER, L.L.4
-
42
-
-
39749131091
-
-
NATIONAL INSTITUTE FOR HEALTH AND EXCELLENCE: Clinical Guideline 23. Depression. Management of Depression in Primary and Secondary Care. HMSO London, UK (2004).
-
NATIONAL INSTITUTE FOR HEALTH AND EXCELLENCE: Clinical Guideline 23. Depression. Management of Depression in Primary and Secondary Care. HMSO London, UK (2004).
-
-
-
-
43
-
-
0034059513
-
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology guidelines
-
ANDERSON IM, NUTT DJ, DEAKIN JRW: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J. Psychopharmacol. (2000) 14:3-20.
-
(2000)
J. Psychopharmacol
, vol.14
, pp. 3-20
-
-
ANDERSON, I.M.1
NUTT, D.J.2
DEAKIN, J.R.W.3
-
45
-
-
1842556548
-
The role of atypical antipsychotics in bipolar depression and anxiety disorders
-
MCINTYRE R, KATZMAN M: The role of atypical antipsychotics in bipolar depression and anxiety disorders. Bipolar. Disord. (2003) 5(S2):20-35.
-
(2003)
Bipolar. Disord
, vol.5
, Issue.S2
, pp. 20-35
-
-
MCINTYRE, R.1
KATZMAN, M.2
-
46
-
-
15744400568
-
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression
-
CALABRESE JR, KEEK PE, MACFADDEN W et al.: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry (2005) 162:1351-1360.
-
(2005)
Am. J. Psychiatry
, vol.162
, pp. 1351-1360
-
-
CALABRESE, J.R.1
KEEK, P.E.2
MACFADDEN, W.3
-
47
-
-
33751116553
-
Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind placebo-controlled study (The BOLDER II Study)
-
THASE ME, MACFADDEN W, WEISLER RH et al.: Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind placebo-controlled study (The BOLDER II Study). J. Clin. Psychopharmacol. (2006) 26:600-609.
-
(2006)
J. Clin. Psychopharmacol
, vol.26
, pp. 600-609
-
-
THASE, M.E.1
MACFADDEN, W.2
WEISLER, R.H.3
-
48
-
-
29344438594
-
Use of atypical antipsychotics in refractory depression and anxiety
-
NEMEROFF CB: Use of atypical antipsychotics in refractory depression and anxiety. J. Clin. Psychiatry (2005) 66(Suppl. 8): 13-21.
-
(2005)
J. Clin. Psychiatry
, vol.66
, Issue.SUPPL. 8
, pp. 13-21
-
-
NEMEROFF, C.B.1
-
49
-
-
29444447124
-
Therapeutic options in the treatment of insomnia
-
ERMAN MK: Therapeutic options in the treatment of insomnia. J. Clin. Psychiatry (2005) 66(Suppl. 9):18-23.
-
(2005)
J. Clin. Psychiatry
, vol.66
, Issue.SUPPL. 9
, pp. 18-23
-
-
ERMAN, M.K.1
-
50
-
-
33744907790
-
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs
-
OLFSON M, BLANCO C, LIU L, MORENO C, LAJE G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch. Gen. Psychiatry (2006) 63:679-685.
-
(2006)
Arch. Gen. Psychiatry
, vol.63
, pp. 679-685
-
-
OLFSON, M.1
BLANCO, C.2
LIU, L.3
MORENO, C.4
LAJE, G.5
-
51
-
-
25844472161
-
Metabolic side effects of atypical antipsychotics in children: A literature review
-
FEDOROWICZ VJ, FOMBONNE E: Metabolic side effects of atypical antipsychotics in children: a literature review. J. Psychophamacol. (2005) 19:533-550.
-
(2005)
J. Psychophamacol
, vol.19
, pp. 533-550
-
-
FEDOROWICZ, V.J.1
FOMBONNE, E.2
-
52
-
-
21744441492
-
Treatment of psychosis in elderly people
-
KARIM S, BYRNE EJ: Treatment of psychosis in elderly people. Adv. Psych. Treatment (2005) 11:286-296.
-
(2005)
Adv. Psych. Treatment
, vol.11
, pp. 286-296
-
-
KARIM, S.1
BYRNE, E.J.2
-
53
-
-
26844538114
-
Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials
-
SCHNEIDER LS, DAGERMAN KS, INSEL P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. J. Am. Med. Assoc. (2005) 294:1934-1943.
-
(2005)
J. Am. Med. Assoc
, vol.294
, pp. 1934-1943
-
-
SCHNEIDER, L.S.1
DAGERMAN, K.S.2
INSEL, P.3
-
54
-
-
2542428510
-
CSM warning on atypical psychotics and stroke may be detrimental for dementia
-
MOWAT D, FOWLIE D: CSM warning on atypical psychotics and stroke may be detrimental for dementia. BMJ (2004) 328:1262.
-
(2004)
BMJ
, vol.328
, pp. 1262
-
-
MOWAT, D.1
FOWLIE, D.2
-
55
-
-
20044375721
-
Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study
-
GILL SS, ROCHON PA, HERRMANN N et al.: Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 330:445-450.
-
(2005)
BMJ
, vol.330
, pp. 445-450
-
-
GILL, S.S.1
ROCHON, P.A.2
HERRMANN, N.3
-
56
-
-
34249660551
-
All-cause mortality associated with typical and atypical antipsychotics in demented outpatients
-
TRIFIRÒ G, VERHAMME KMC, ZIERE G et al.: All-cause mortality associated with typical and atypical antipsychotics in demented outpatients. Pharmacoepidemiol. Drug Saf. (2007) 16:538-544.
-
(2007)
Pharmacoepidemiol. Drug Saf
, vol.16
, pp. 538-544
-
-
TRIFIRÒ, G.1
VERHAMME, K.M.C.2
ZIERE, G.3
-
57
-
-
28244431743
-
Risk of death in elderly users of conventional vs. atypical antipsychotic medications
-
WANG PS, SCHNEEWEISS S, AVORN J et al.: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N. Engl. J. Med. (2005) 353:2335-2341.
-
(2005)
N. Engl. J. Med
, vol.353
, pp. 2335-2341
-
-
WANG, P.S.1
SCHNEEWEISS, S.2
AVORN, J.3
-
58
-
-
34250631300
-
Antipsychotic drug use and mortality in older adults with dementia
-
GILL SS, BRONSKILL SE, NORMAND SLT et al.: Antipsychotic drug use and mortality in older adults with dementia. Ann. Intern. Med. (2007) 146:775-786.
-
(2007)
Ann. Intern. Med
, vol.146
, pp. 775-786
-
-
GILL, S.S.1
BRONSKILL, S.E.2
NORMAND, S.L.T.3
-
59
-
-
0033595555
-
A randomized trial of risperidone, placebo and haloperidol for behavioural symptoms of dementia
-
DE DEYN PP, RABHERU K, RASMUSSEN A et al.: A randomized trial of risperidone, placebo and haloperidol for behavioural symptoms of dementia. Neurology (1999) 53:946-955.
-
(1999)
Neurology
, vol.53
, pp. 946-955
-
-
DE DEYN, P.P.1
RABHERU, K.2
RASMUSSEN, A.3
-
60
-
-
0032966714
-
Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia
-
KATZ IR, JESTE DV, MINTZER JE, et al.: Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia. J. Clin. Psychiatry (1999) 60:107-115.
-
(1999)
J. Clin. Psychiatry
, vol.60
, pp. 107-115
-
-
KATZ, I.R.1
JESTE, D.V.2
MINTZER, J.E.3
-
61
-
-
0033799993
-
Olanzapine treatment for psychotics and behavioural symptoms in patients with Alzheimer's disease in nursing care facilities: A double blind, randomized, placebo-controlled trial: the HGEU Study Group
-
STREET JS, CLARK WS, GANNON KS et al.: Olanzapine treatment for psychotics and behavioural symptoms in patients with Alzheimer's disease in nursing care facilities: a double blind, randomized, placebo-controlled trial: the HGEU Study Group. Arch. Gen. Psychiatry (2000) 57:968-976.
-
(2000)
Arch. Gen. Psychiatry
, vol.57
, pp. 968-976
-
-
STREET, J.S.1
CLARK, W.S.2
GANNON, K.S.3
-
62
-
-
0035674311
-
A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients
-
CHAN WC, LAM LC, CHOY CN: A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int. J. Geriatr. Psychiatry (2001) 16:1156-1162.
-
(2001)
Int. J. Geriatr. Psychiatry
, vol.16
, pp. 1156-1162
-
-
CHAN, W.C.1
LAM, L.C.2
CHOY, C.N.3
-
63
-
-
0037328229
-
A randomized placebo-controlled trial of risperidone for the treatment of agitation, aggression and psychosis of dementia
-
BRODATY H, AMES D, SNOWDON J: A randomized placebo-controlled trial of risperidone for the treatment of agitation, aggression and psychosis of dementia. J. Clin. Psychiatry (2003) 64:134-143.
-
(2003)
J. Clin. Psychiatry
, vol.64
, pp. 134-143
-
-
BRODATY, H.1
AMES, D.2
SNOWDON, J.3
-
64
-
-
33749618085
-
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
-
SCHNEIDER IS, TARIOT PN, DAGERMAN KSL et al.: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N. Engl. J. Med. (2006) 355:1525-1538.
-
(2006)
N. Engl. J. Med
, vol.355
, pp. 1525-1538
-
-
SCHNEIDER, I.S.1
TARIOT, P.N.2
DAGERMAN, K.S.L.3
-
65
-
-
4544335523
-
Drug treatment for personality disorders
-
TYRER P, BATEMAN AW: Drug treatment for personality disorders. Advan. Psychiatr. Treat. (2004) 10:389-398.
-
(2004)
Advan. Psychiatr. Treat
, vol.10
, pp. 389-398
-
-
TYRER, P.1
BATEMAN, A.W.2
-
66
-
-
0020360014
-
Pharmacological prevention of suicidal behaviour
-
MONTGOMERY SA, MONTGOMERY D: Pharmacological prevention of suicidal behaviour. J. Affect. Disord. (1982) 4:291-298.
-
(1982)
J. Affect. Disord
, vol.4
, pp. 291-298
-
-
MONTGOMERY, S.A.1
MONTGOMERY, D.2
-
67
-
-
85047697000
-
Aripiprazole in the treatment of patients with borderline personality disorder: A double-blind, placebo controlled study
-
NICKEL MK, MUEHLBACHER M, NICKEL C et al.: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo controlled study. Am. J. Psychiatry (2006) 163:833-838.
-
(2006)
Am. J. Psychiatry
, vol.163
, pp. 833-838
-
-
NICKEL, M.K.1
MUEHLBACHER, M.2
NICKEL, C.3
-
68
-
-
0038266769
-
Risperidone in the treatment of schizotypal personality disorder
-
KOENIGSBERG HW, REYNOLDS D, GOODMAN M et al.: Risperidone in the treatment of schizotypal personality disorder. J. Clin. Psychiatry (2003) 64:628-634.
-
(2003)
J. Clin. Psychiatry
, vol.64
, pp. 628-634
-
-
KOENIGSBERG, H.W.1
REYNOLDS, D.2
GOODMAN, M.3
-
69
-
-
33645515279
-
Pharmacological interventions for people with borderline personality disorder
-
BINKS CA, FENTON M, MCCARTHY L et al.: Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst. Rev. (2006) 1.
-
(2006)
Cochrane Database Syst. Rev
, pp. 1
-
-
BINKS, C.A.1
FENTON, M.2
MCCARTHY, L.3
-
71
-
-
0029072051
-
Prescribing of potentially harmful drugs to patients admitted to hospital after head injury
-
GOLDSTEIN LB: Prescribing of potentially harmful drugs to patients admitted to hospital after head injury. J. Neurol. Neurosurg. Psychiatry (1995) 58:753-755.
-
(1995)
J. Neurol. Neurosurg. Psychiatry
, vol.58
, pp. 753-755
-
-
GOLDSTEIN, L.B.1
-
72
-
-
39049176339
-
Pharmacological management for agitation and aggression in people with acquired brain injury
-
CD003299
-
FLEMINGER S, GREENWOOD RJ, OLIVER DL: Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst. Rev. (2006), 4:CD003299.
-
(2006)
Cochrane Database Syst. Rev
, vol.4
-
-
FLEMINGER, S.1
GREENWOOD, R.J.2
OLIVER, D.L.3
-
73
-
-
0035138025
-
Methotrimeprazine in the treatment of agitation in acquired brain injury patients
-
MARYNIAK O, MANCHANDA R, VELANI A: Methotrimeprazine in the treatment of agitation in acquired brain injury patients. Brain Inj. (2001) 15:167-174.
-
(2001)
Brain Inj
, vol.15
, pp. 167-174
-
-
MARYNIAK, O.1
MANCHANDA, R.2
VELANI, A.3
-
74
-
-
0038045267
-
Managing agitation and aggression after head injury
-
FLEMINGER S: Managing agitation and aggression after head injury. BMJ (2003) 327:4-5.
-
(2003)
BMJ
, vol.327
, pp. 4-5
-
-
FLEMINGER, S.1
-
75
-
-
16544387381
-
Antipsychotic medication for challenging behaviour in people with learning disability
-
CD000377
-
BRYLEWSKI J, DUGGAN L: Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database Syst. Rev. (2004), 3:CD000377.
-
(2004)
Cochrane Database Syst. Rev
, vol.3
-
-
BRYLEWSKI, J.1
DUGGAN, L.2
-
76
-
-
11844269286
-
Withdrawal of antipsychotic drugs from adults with intellectual disabilities
-
STEVENSON C, RAJAN L, REID G et al.: Withdrawal of antipsychotic drugs from adults with intellectual disabilities. Ir. J. Psych. Med. (2004) 21:85-90.
-
(2004)
Ir. J. Psych. Med
, vol.21
, pp. 85-90
-
-
STEVENSON, C.1
RAJAN, L.2
REID, G.3
-
77
-
-
23944435978
-
Evidence-based practices in intellectual disability and behaviour disorders
-
GREY IM, HASTINGS RP: Evidence-based practices in intellectual disability and behaviour disorders. Curr. Opin. Psychiatry (2005) 18:469-475.
-
(2005)
Curr. Opin. Psychiatry
, vol.18
, pp. 469-475
-
-
GREY, I.M.1
HASTINGS, R.P.2
-
81
-
-
1942507400
-
The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder
-
KANT R, CHALANSANI R, CHENGAPPA RN, DIERINGER MF: The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder. J. Child Adolesc. Psychopharmacol. (2004) 14:57-63.
-
(2004)
J. Child Adolesc. Psychopharmacol
, vol.14
, pp. 57-63
-
-
KANT, R.1
CHALANSANI, R.2
CHENGAPPA, R.N.3
DIERINGER, M.F.4
-
82
-
-
0028348949
-
The use of high-dose antipsychotic medication
-
THOMPSON C: The use of high-dose antipsychotic medication. Br. J. Psychiatry (1994) 164:448458.
-
(1994)
Br. J. Psychiatry
, vol.164
, pp. 448458
-
-
THOMPSON, C.1
-
83
-
-
0036849024
-
The results of a multi-centre audit of prescribing of antipsychotic drugs for inpatients in the UK
-
HARRINGTON M, LELLIOTT P, PATON C et al.: The results of a multi-centre audit of prescribing of antipsychotic drugs for inpatients in the UK. Psychiatr. Bull. (2002) 26:414-418.
-
(2002)
Psychiatr. Bull
, vol.26
, pp. 414-418
-
-
HARRINGTON, M.1
LELLIOTT, P.2
PATON, C.3
-
84
-
-
27744452819
-
Prescribing of antipsychotic medication in a Medicaid population: Use of polytherapy and off-label dosages
-
KOGUT SJ, YAM F, DUFRESNE R: Prescribing of antipsychotic medication in a Medicaid population: use of polytherapy and off-label dosages. J. Manag. Care Pharm. (2005) 11:17-24.
-
(2005)
J. Manag. Care Pharm
, vol.11
, pp. 17-24
-
-
KOGUT, S.J.1
YAM, F.2
DUFRESNE, R.3
-
85
-
-
3142700764
-
High dose antipsychotic use in schizophrenia: Findings of the REAP (Research on East Asia psychotropic prescriptions) study
-
SIM K, SU A, LEONG JY et al.: High dose antipsychotic use in schizophrenia: findings of the REAP (Research on East Asia psychotropic prescriptions) study. Pharmacopsychiatry (2004) 37:175-179.
-
(2004)
Pharmacopsychiatry
, vol.37
, pp. 175-179
-
-
SIM, K.1
SU, A.2
LEONG, J.Y.3
-
86
-
-
39749185470
-
Dose form modification - a common but potentially hazardous practice. A literature review and a study of medication administration
-
In Press
-
STUBBS J, HAW C, DICKENS G: Dose form modification - a common but potentially hazardous practice. A literature review and a study of medication administration. Int. Psychogeriatr. (In Press).
-
Int. Psychogeriatr
-
-
STUBBS, J.1
HAW, C.2
DICKENS, G.3
-
87
-
-
0033968969
-
Antipsychotics - the future of schizophrenia treatment
-
BEAUMONT G: Antipsychotics - the future of schizophrenia treatment. Curr. Med. Res. Opin. (2000) 16(1):37-42.
-
(2000)
Curr. Med. Res. Opin
, vol.16
, Issue.1
, pp. 37-42
-
-
BEAUMONT, G.1
-
88
-
-
0024264554
-
The role of neuroleptics in manic-depressive illness
-
KANE JM: The role of neuroleptics in manic-depressive illness. J. Clin. Psychiatry (1988) 49(Suppl.):12-14.
-
(1988)
J. Clin. Psychiatry
, vol.49
, Issue.SUPPL.
, pp. 12-14
-
-
KANE, J.M.1
-
89
-
-
3042785965
-
Tardive dyskinesia rates with atypical antipsychotics in adults: Prevalence and incidence
-
KANE JM: Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J. Clin. Psychiatry (2004) 65(Suppl. 9): 16-20.
-
(2004)
J. Clin. Psychiatry
, vol.65
, Issue.SUPPL. 9
, pp. 16-20
-
-
KANE, J.M.1
-
90
-
-
24344449718
-
The safety and tolerability of atypical antipsychotics in bipolar disorder
-
SEEMULLER F, FORSTHOFF A, DITTMENN S et al.: The safety and tolerability of atypical antipsychotics in bipolar disorder. Expert Opin. Drug Saf. (2005) 4:849-868.
-
(2005)
Expert Opin. Drug Saf
, vol.4
, pp. 849-868
-
-
SEEMULLER, F.1
FORSTHOFF, A.2
DITTMENN, S.3
-
91
-
-
25444513136
-
Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: A systematic study of tolerability and use in different diagnostic groups
-
CURRAN S, TURNER D, MUSA S, WATTIS J: Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups. Int. J. Geriatr. Psychiatry (2005) 20:842-847.
-
(2005)
Int. J. Geriatr. Psychiatry
, vol.20
, pp. 842-847
-
-
CURRAN, S.1
TURNER, D.2
MUSA, S.3
WATTIS, J.4
-
92
-
-
1842739590
-
Adverse metabolic effects associated with atypical antipsychotics
-
MELKERSSON K, DAHL ML: Adverse metabolic effects associated with atypical antipsychotics. Drugs (2004) 64:701-723.
-
(2004)
Drugs
, vol.64
, pp. 701-723
-
-
MELKERSSON, K.1
DAHL, M.L.2
-
93
-
-
16644392426
-
Abnormalities of glucose metabolism associated with atypical antipsychotic drugs
-
NEWCOMER JW: Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. J. Clin. Psychiatry (2004) 65(Suppl. 18):36-46.
-
(2004)
J. Clin. Psychiatry
, vol.65
, Issue.SUPPL. 18
, pp. 36-46
-
-
NEWCOMER, J.W.1
-
94
-
-
0034121256
-
Atypical antipsychotics and weight gain - a systematic review
-
TAYLOR DM, MCASKILL R: Atypical antipsychotics and weight gain - a systematic review. Acta Psych. Scand. 101:416-432.
-
Acta Psych. Scand
, vol.101
, pp. 416-432
-
-
TAYLOR, D.M.1
MCASKILL, R.2
-
95
-
-
0037318271
-
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY) pt 1: A review
-
SCHURR SB, SIKICH L, FINDLING RL et al.: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY) pt 1: a review. J. Am. Acad. Adolesc. Psychiatry (2003) 42:132-144.
-
(2003)
J. Am. Acad. Adolesc. Psychiatry
, vol.42
, pp. 132-144
-
-
SCHURR, S.B.1
SIKICH, L.2
FINDLING, R.L.3
-
96
-
-
0032958401
-
Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs
-
LEIPZIG RM, CUMMINGS RG, TINETTI ME: Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J. Am. Geriatr. Soc. (1999) 47(1):30-39.
-
(1999)
J. Am. Geriatr. Soc
, vol.47
, Issue.1
, pp. 30-39
-
-
LEIPZIG, R.M.1
CUMMINGS, R.G.2
TINETTI, M.E.3
-
97
-
-
25144510914
-
Atypical antipsychotic medications and risk of falls in residents of aged care facilities
-
HIEN LE TT, CUMMING RG, CAMERON ID et al.: Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J. Am. Geriatr. Soc. (2005) 53(8): 1290-1295.
-
(2005)
J. Am. Geriatr. Soc
, vol.53
, Issue.8
, pp. 1290-1295
-
-
HIEN, L.T.1
CUMMING, R.G.2
CAMERON, I.D.3
-
99
-
-
0034712552
-
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
-
REILLY JG, AYIS SA, FERRIER IN, JONES SJ, THOMAS SH: QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet (2000) 355(9209):1048-1052.
-
(2000)
Lancet
, vol.355
, Issue.9209
, pp. 1048-1052
-
-
REILLY, J.G.1
AYIS, S.A.2
FERRIER, I.N.3
JONES, S.J.4
THOMAS, S.H.5
|